Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) Bundle
Shaanxi Beiyuan Chemical's recent financial picture demands a close look: revenue for the nine months to September 30, 2025 fell to CNY 6.76 billion (down 10.24% year‑over‑year) with TTM revenue at CNY 9.33 billion (‑7.67% YoY) and full‑year 2024 sales of CNY 10.08 billion, while market sentiment prices the firm at a market capitalization of CNY 15.77 billion (share price CNY 3.99 as of Nov 5, 2025) despite a slim trailing net profit margin of 2.29% and EPS of CNY 0.05 (P/E 73.29), juxtaposed with an EBITDA margin of 9.11% and ROE of 1.8%; balance sheet and liquidity indicators include operating cash flow of CNY 1.26 billion, short‑term assets of CNY 5.1 billion, a very low debt‑to‑equity ratio of 0.19%, a dividend yield of 2.70% (ex‑dividend July 7, 2025), low beta of 0.19, and a notable insider shift as Hengyuan Investment trimmed its stake from 25.60% to 24.65% on May 12, 2025-dig into the full article for detailed revenue, profitability, leverage, valuation and risk analyses that investors should weigh before the upcoming earnings release on April 24, 2026
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Revenue Analysis
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. reported weakening top-line performance through 2024-2025, with noticeable declines in both period and trailing figures. Key numeric takeaways below quantify the trend and market valuation context.- Nine months ending Sep 30, 2025 revenue: CNY 6.76 billion (down 10.24% vs. same period 2024)
- TTM revenue as of Sep 30, 2025: CNY 9.33 billion (down 7.67% YoY)
- Full-year 2024 revenue: CNY 10.08 billion (down 8.10% YoY)
- Revenue per employee: ~CNY 2.39 million (3,912 employees)
- Price-to-Sales (P/S) ratio: 1.69
- Market capitalization: CNY 15.77 billion; share price: CNY 3.99 (as of Nov 5, 2025)
| Metric | Amount (CNY) | Period | YoY Change |
|---|---|---|---|
| Revenue (9M) | 6,760,000,000 | Jan-Sep 30, 2025 | -10.24% |
| Revenue (TTM) | 9,330,000,000 | Trailing 12 months to Sep 30, 2025 | -7.67% |
| Revenue (FY) | 10,080,000,000 | Full year 2024 | -8.10% |
| Employees | 3,912 | As reported | - |
| Revenue per employee | 2,390,000 | As reported | - |
| Market capitalization | 15,770,000,000 | As of Nov 5, 2025 | - |
| Share price | 3.99 | As of Nov 5, 2025 | - |
| Price-to-Sales (P/S) | 1.69 | Market metric | - |
- The YoY declines across 2024 and the TTM to Sep 30, 2025 indicate contraction in demand or pricing pressure affecting core chemical product lines.
- Revenue per employee (~CNY 2.39M) provides an efficiency snapshot versus peers in specialty chemicals and bulk chemical manufacturing.
- P/S of 1.69 and market cap of CNY 15.77B show the market is valuing the company at roughly 1.7x trailing sales, a useful comparator for valuation against sector averages.
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Profitability Metrics
The following section distills the key profitability indicators for Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS), focusing on the most recent trailing twelve months (TTM) ending September 30, 2025, and the full-year 2024 results where relevant.
| Metric | Value | Notes / Period |
|---|---|---|
| Net Profit Margin | 2.29% | TTM ending 2025-09-30 |
| Operating Profit Margin | 3.33% | TTM ending 2025-09-30 |
| EBITDA Margin | 9.11% (YoY Δ -6.63%) | TTM ending 2025-09-30 |
| Net Income (Fiscal 2024) | CNY 235.56 million (-36.8% YoY) | Fiscal year 2024 |
| Earnings Per Share (EPS) | CNY 0.05 | TTM ending 2025-09-30 |
| Price-to-Earnings (P/E) Ratio | 73.29 | TTM ending 2025-09-30 |
| Return on Equity (ROE) | 1.8% | TTM ending 2025-09-30 |
- Low net profit margin (2.29%) signals limited bottom-line conversion from revenues despite a higher EBITDA margin (9.11%), indicating significant non-operating costs, depreciation, interest, or tax drag.
- EPS of CNY 0.05 combined with a high P/E of 73.29 implies market pricing that expects future earnings recovery or low current earnings relative to share price.
- A sizable drop in 2024 net income to CNY 235.56 million (-36.8% YoY) underscores recent earnings volatility and pressure on profitability drivers.
- Operating margin at 3.33% shows slim operating profitability-margins are tight in core activities.
- ROE of 1.8% indicates limited efficiency in converting shareholders' equity into net income; capital base is producing low returns.
- EBITDA margin decline of 6.63% YoY signals operating performance deterioration before non-cash and financing items.
For context on strategic direction and corporate goals that may affect future profitability, see the company's guiding statements: Mission Statement, Vision, & Core Values (2026) of Shaanxi Beiyuan Chemical Industry Group Co., Ltd.
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Debt vs. Equity Structure
Shaanxi Beiyuan Chemical exhibits a conservatively financed capital structure with very low leverage and stable equity backing. The headline metric - a total debt-to-equity ratio of 0.19% - signals minimal reliance on borrowed capital and places the company among the lowest-levered firms in its sector. This low leverage affects risk profile, interest burden, and flexibility for capex or dividend policies.- Total debt-to-equity: 0.19% - implies debt is negligible relative to shareholders' equity.
- Market capitalization: CNY 15.77 billion (stock price CNY 3.99 as of 2025-11-05).
- Beta: 0.19 - low volatility versus broader market, indicating defensive share behavior.
- Dividend yield: 2.70% with ex-dividend date 2025-07-07 - supports income-oriented investors.
- Significant shareholder movement: Hengyuan Investment trimmed stake by 2% on 2025-05-12 (from 25.60% to 24.65%).
- Next earnings release scheduled for 2026-04-24 - important for re-assessing leverage and profitability.
| Metric | Value | Implication |
|---|---|---|
| Total debt-to-equity | 0.19% | Minimal financial leverage; low interest risk |
| Market capitalization | CNY 15.77 billion | Mid-cap scale; liquidity context for investors |
| Share price (2025-11-05) | CNY 3.99 | Reference price for valuation multiples |
| Beta | 0.19 | Lower systematic volatility |
| Dividend yield | 2.70% | Provides modest cash return to shareholders |
| Major shareholder change | Hengyuan: 25.60% → 24.65% (-2%) on 2025-05-12 | Minor reduction; monitor for further exits or strategic moves |
| Next earnings date | 2026-04-24 | Upcoming data point to confirm balance sheet trends |
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Liquidity and Solvency
Shaanxi Beiyuan Chemical Industry Group reports operating cash flow of CNY 1.26 billion, which provides near-term funding for operations, working capital needs and interest/service obligations.- Operating cash flow: CNY 1.26 billion
- Short-term assets (current assets): CNY 5.10 billion
- Short-term assets coverage: comfortably covers short-term liabilities based on reported balances
| Metric | Value / Note |
|---|---|
| Operating cash flow | CNY 1.26 billion |
| Short-term (current) assets | CNY 5.10 billion |
| Current ratio | Not specified in the available data |
| Quick ratio | Not specified in the available data |
| Interest coverage ratio | Not specified in the available data |
| Debt-to-assets ratio | Not specified in the available data |
- Positive operating cash flow supports ongoing operations and reduces reliance on short-term borrowing.
- Reported CNY 5.10 billion in short-term assets indicates a solid current-asset base relative to typical working-capital needs.
- Absent explicit ratios (current, quick, interest coverage, debt-to-assets) limits precise assessment of liquidity cushions and leverage; investors should seek these ratios or underlying balance-sheet detail for a fuller picture.
- For complementary context on corporate direction and capital priorities, see Mission Statement, Vision, & Core Values (2026) of Shaanxi Beiyuan Chemical Industry Group Co., Ltd.
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Valuation Analysis
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) is currently priced at CNY 3.99 per share (as of November 5, 2025) with a market capitalization of CNY 15.77 billion. Key headline valuation and market metrics point to a stock that carries a relatively high earnings multiple but modest revenue multiple and low market volatility.- Price-to-Sales (P/S): 1.69 - implies the market values each yuan of revenue at 1.69 yuan of equity market value.
- Price-to-Earnings (P/E): 73.29 - signaling a high valuation relative to reported earnings, which may reflect growth expectations or compressed near-term profit base.
- Market Capitalization: CNY 15.77 billion - size positioning within its sector and liquidity considerations for institutional investors.
- Share Price (Nov 5, 2025): CNY 3.99.
- Beta: 0.19 - indicates substantially lower historical volatility versus the broader market.
- Dividend Yield: 2.70% - provides an income component; ex-dividend date: July 7, 2025.
- Earnings Date: scheduled April 24, 2026 - next formal update for earnings-driven valuation reassessment.
| Metric | Value | Implication |
|---|---|---|
| Share Price (CNY) | 3.99 | Current market quote (Nov 5, 2025) |
| Market Capitalization (CNY) | 15.77 billion | Company size |
| P/S Ratio | 1.69 | Moderate revenue multiple |
| P/E Ratio | 73.29 | High earnings multiple; earnings-based valuation elevated |
| Beta | 0.19 | Low volatility relative to market |
| Dividend Yield | 2.70% | Regular income element; ex-dividend 2025-07-07 |
| Next Earnings Date | 2026-04-24 | Upcoming catalyst for revaluation |
- High P/E (73.29) relative to peers typically signals market expectations of above-average future earnings growth or a temporarily depressed earnings base; investors should compare with sector medians and forward P/E.
- P/S of 1.69 suggests the stock is not extremely expensive on a revenue basis; analyzing revenue growth rates and margin expansion potential is essential.
- Low beta (0.19) makes the stock appealing for risk-averse allocations but may also indicate limited upside sensitivity to market rallies.
- Dividend yield of 2.70% adds a modest cash return; confirm sustainability by reviewing payout ratio and cash flow in the latest financials ahead of the April 24, 2026 earnings release.
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Risk Factors
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) faces several material risks tied to industry structure, margins, capital efficiency, cash generation and balance-sheet composition. Investors should weigh these against the company's scale, cash flow and liquidity positions.- Industry competitiveness: the Chinese chemical sector rewards scale, vertical integration and cost control; smaller or less-integrated players face margin pressure and volatility.
- Modest profitability: net profit margin of 2.29% leaves limited buffer for adverse price movements, raw material cost inflation or one-off charges.
- Low capital efficiency: ROE of 1.8% indicates weak conversion of equity into shareholder returns - growth funded by equity may deliver limited incremental profit.
- EBITDA deterioration: EBITDA margin at 9.11% with a year-over-year decline of 6.63% signals margin compression and potential operational or pricing challenges.
- Cash flow dependency: operating cash flow of CNY 1.26 billion supports ongoing operations but must be monitored against capex, debt servicing and working capital needs.
- Liquidity profile: short-term assets of CNY 5.1 billion provide near-term coverage for liabilities, but liquidity quality (cash vs. receivables/inventory) matters for stress scenarios.
| Metric | Value | Notes |
|---|---|---|
| Net Profit Margin | 2.29% | Modest profitability |
| Return on Equity (ROE) | 1.8% | Low returns on shareholders' equity |
| EBITDA Margin | 9.11% | YoY decline: 6.63% |
| Operating Cash Flow | CNY 1.26 billion | Supports operations and near-term obligations |
| Short-term Assets | CNY 5.1 billion | Comfortably covers short-term liabilities |
| Industry Exposure | Chinese chemical industry | High competition; sensitivity to raw-material and energy prices |
- Key downside scenarios: sustained raw-material price increases, prolonged product-price weakness, loss of key customers, operational disruptions or renewed regulatory tightening in chemical production and environmental compliance.
- Balance-sheet/operational mitigants: positive operating cash flow and CNY 5.1 billion in short-term assets provide liquidity headroom; strategic actions to improve margins (cost cuts, product mix shift, scale-up) would be necessary to restore ROE.
- Monitoring checklist for investors: quarterly EBITDA trend, margin recovery initiatives, working-capital turns, composition of short-term assets (cash vs. receivables/inventory), and any changes in leverage or dividend policy.
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) - Growth Opportunities
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) presents several measurable strengths that underpin near- to medium-term growth potential. Key financial and market indicators show resilient liquidity, modest volatility versus the market, and an investor income component via dividends.| Metric | Value | Notes / Date |
|---|---|---|
| Operating Cash Flow | CNY 1.26 billion | Supports ongoing operations |
| Short-term Assets | CNY 5.1 billion | Comfortably covers short-term liabilities |
| Market Capitalization | CNY 15.77 billion | Company size indicator |
| Stock Price | CNY 3.99 | As of November 5, 2025 |
| Beta | 0.19 | Low volatility vs. broader market |
| Dividend Yield | 2.70% | Ex-dividend date: July 7, 2025 |
| Next Earnings Date | April 24, 2026 | Scheduled release |
- Strong liquidity cushion: CNY 5.1 billion in short-term assets and CNY 1.26 billion operating cash flow reduce refinancing risk and support capital allocation to growth initiatives.
- Stable investor return profile: a 2.70% dividend yield with a recently observed ex-dividend date indicates commitment to shareholder distributions while retaining cash for operations.
- Low market sensitivity: beta of 0.19 implies share price is less reactive to market swings, attractive for investors seeking defensive exposure within the chemical sector.
- Reinvestment capacity: positive operating cash flow creates room for targeted capex or R&D to expand specialty chemical lines or downstream integration.
- Balance sheet flexibility: short-term asset coverage provides negotiation leverage for strategic M&A or partnership financing without immediate dilution.
- Valuation and liquidity trade-off: market cap of CNY 15.77 billion and stock price at CNY 3.99 may present entry opportunities for long-term investors if operational momentum improves.
| Potential Growth Levers | How the Company Is Positioned |
|---|---|
| Capacity expansion | Fundable via operating cash flow and short-term assets; can target higher-margin specialty products. |
| Product mix optimization | Dividend and low volatility support strategic patience for margin-improving shifts. |
| M&A or joint ventures | Balance-sheet liquidity enables selective acquisitions or partnerships to accelerate market access. |
| Investor confidence | Consistent dividend yield and low beta attract income and defensive investors, potentially supporting share price stability. |
- Timing considerations: monitor the April 24, 2026 earnings release for updated revenue, margin, and cash-flow trends that could validate growth initiatives.
- Monitor market liquidity and price action around ex-dividend and earnings dates (ex-dividend: July 7, 2025) for short-term volatility opportunities.

Shaanxi Beiyuan Chemical Industry Group Co., Ltd. (601568.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.